Filling in fat from dead donors is the new rage among wealthy executives in the US, who like the speed and convenience of the procedure.
A new aesthetic procedure that uses fat from deceased donors is gaining popularity among wealthy executives looking for subtle body improvements without surgery, general anesthesia or a long recovery period.
The product, called alloClaeis being adopted by a growing number of plastic surgeons in the United States and is marketed as a minimally invasive alternative to traditional implants or a client’s own fat transfer.
Developed by Tiger Aesthetics, alloClae uses purified fat collected from deceased donors who intended his body for medical use. The fat is rigorously selected, processed and injected as body filler, mainly to contour the breasts, hips, shoulders and chest. Unlike conventional procedures, alloClae can be administered under local anesthesia, allowing patients to return to work the same day.
Plastic surgeons in New York and California report strong demand from corporate professionals who want to improve their appearance without interrupting your schedules busy. Some patients even make appointments early in the morning and participate in meetings immediately afterwards.
Sachin Sridharania New York plastic surgeon who participated in the alloClae clinical trials, said he has performed more than 50 procedures with the product, with some patients taking work calls during treatment. “People are pay for convenience“, he told .
The increase in demand has been driven, in part, by the widespread use of weight loss medications such as Ozempic, which can lead to loss of volume in areas such as the hips, buttocks and breasts.
Tiger Aesthetics began offering alloClae to a select group of physicians in late 2024 and plans to expand to a wider audience in 2026. The company says supply is currently limited as production depends on donated human tissuewhich generates waiting lists and shortages. Prices vary widely, from around $10,000 to $100,000, depending on the volume used, with some patients receiving hundreds of cubic centimeters of filler.
The product is regulated by the US Food and Drug Administration (FDA) under a different classification than implants or injectable medicines. Although there are similar products based on donated fat, alloClae stands out due to the large volumes used and not recommended for facials.
Experts warn that long-term results are not yet fully known. Although initial results appear promising, data beyond short-term follow-up are limited. Still, interest continues to grow, with patients increasingly requesting the product by name.
